Karyopharm Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.56
|
|
Average Rating
|
3.78
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.57
|
-0.45
|
0.12
|
21.05%
|
|
2022-06-30
|
-0.63
|
-0.62
|
0.01
|
1.59%
|
|
2022-03-31
|
-0.63
|
-0.53
|
0.10
|
15.87%
|
|
2021-12-31
|
-0.52
|
0.46
|
0.98
|
188.46%
|
|
2021-09-30
|
-0.67
|
-0.69
|
-0.02
|
-2.99%
|
|
2021-06-30
|
-0.75
|
-0.71
|
0.04
|
5.33%
|
|
2021-03-31
|
-0.71
|
-0.77
|
-0.06
|
-8.45%
|
|
2020-12-31
|
-0.59
|
-0.59
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.60
|
|
2021-12-31
|
-1.71
|
|
2020-12-31
|
-2.73
|
|
2019-12-31
|
-3.23
|
|
2018-12-31
|
-3.13
|
|
2017-12-31
|
-2.80
|
|
2016-12-31
|
-2.93
|
|
2015-12-31
|
-3.32
|
|
2014-12-31
|
-2.41
|
|
2013-12-31
|
-2.31
|